SUBSCRIBE
SUBSCRIBE
News   Policy

Teva Pharmaceutical Industries Limited Comments on Patent Infringement Lawsuit Filed by Momenta Pharmaceuticals, Inc. and Sandoz, Inc.

December 3, 2010 | 
1 min read

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) commented today on the patent infringement lawsuit filed by Momenta Pharmaceuticals, Inc. and Sandoz Inc.

Legal Asia
MORE ON THIS TOPIC
Novartis' office building in Marburg, Germany
Patents
Novartis Scrambles to Squelch Copycats as Generics Gain Ground
January 17, 2025
 · 
2 min read
 · 
Tristan Manalac
Pictured: Boehringer Ingelheim sign on a building/
Schizophrenia
Boehringer Suffers Phase III Schizophrenia Fail, Legal Parry by HHS
January 17, 2025
 · 
2 min read
 · 
Tristan Manalac
Art collage, hands and scales of justice. The concept of the law of the judge.
Legal
HHS Says Vertex is ‘Grasping at Straws’ With Casgevy Fertility Suit
January 16, 2025
 · 
2 min read
 · 
Tristan Manalac
Entrance of the FTC in Washington, DC
Policy
Pharmacy Benefits Managers Netted Extra $7.3B by Inflating Drug Prices: FTC
January 15, 2025
 · 
2 min read
 · 
Dan Samorodnitsky